U.S. judge invalidates Mallinckrodt patents on respiratory treatment

(Reuters) - A federal judge in Delaware on Tuesday invalidated patents held by Mallinckrodt Pharmaceuticals on its Inomax respiratory treatment system.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news